SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR EFFICACY AND SAFETY RESULTS FROM PHASE 3 FUTURE 1 TRIAL

被引：7

作者：

Mease, P. J. ^{[1
,2
]}

Kavanaugh, A. ^{[3
]}

Reimold, A. ^{[4
]}

Tahir, H. ^{[5
]}

Rech, J. ^{[6
]}

Hall, S. ^{[7
]}

Geusens, P. ^{[8
,9
]}

Pascale, P. ^{[10
]}

Delicha, E. M. ^{[10
]}

Pricop, L. ^{[11
]}

Mpofu, S. ^{[10
]}

机构：

[1] Swedish Med Ctr, Seattle, WA USA

[2] Univ Washington, Seattle, WA 98195 USA

[3] UC San Diego Sch Med, La Jolla, CA USA

[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[5] Barts Hlth NHS Trust, London, England

[6] Univ Erlangen Nurnberg, Erlangen, Germany

[7] Monash Univ, Melbourne, Vic, Australia

[8] Univ Hasselt, Hasselt, Belgium

[9] Maastricht Univ Hosp, Maastricht, Netherlands

[10] Novartis Pharma AG, Basel, Switzerland

[11] Novartis Pharmaceut, E Hanover, NJ USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷

关键词：

D O I：

10.1136/annrheumdis-2017-eular.1260

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0470

引用

页码：952 / 953

页数：2

共 50 条

[1] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM THE PHASE 3 FUTURE 2 STUDY
Nash, P.
McInnes, I. B.
Rahman, P.
Gottlieb, A. B.
Kirkham, B.
Ding, K.
Pricop, L.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 379 - 379
[2] Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis through 3 Years: Efficacy and Safety Results from a Phase 3 Trial
Mease, Philip J.
Kavanaugh, Arthur
Reimold, Andreas
Tahir, Hasan
Rech, Juergen
Hall, Stephen
Geusens, Piet
Pascale, Pellet
Delicha, Evie Maria
Pricop, Luminita
Mpofu, Shephard
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[3] Secukinumab Provides Sustained Improvements in the Signs and Symptoms in Psoriatic Arthritis: Final 5 Year Efficacy and Safety Results from a Phase 3 Trial
Mease, Philip J.
Kavanaugh, Arthur
Reimold, Andreas
Tahir, Hasan
Rech, Juergen
Hall, Stephen
Geusens, Piet
Pascale, Pellet
Delicha, Evie Maria
Pricop, Luminita
Mpofu, Shephard
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[4] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5 YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL
Mease, Philip J.
Kavanaugh, Arthur
Reimold, Andreas
Tahir, Hasan
Rech, Juergen
Hall, Stephen
Geusens, Piet
Pellet, Pascale
Delicha, Eumorphia Maria
Pricop, Luminita
Mpofu, Shephard
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 917 - 917
[5] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5-YEAR EFFICACY AND SAFETY RESULTS FROM THE FUTURE 1 PHASE 3 TRIAL
Tahir, Hasan
Mease, Philip J.
Kavanaugh, Arthur
Reimold, Andreas
Rech, Juergen
Hall, Stephen
Geusens, Piet
Pellet, Pascale
Delicha, Eumorphia Maria
Pricop, Luminita
Mpofu, Shephard
RHEUMATOLOGY, 2019, 58 : 151 - 151
[6] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS (PSA) THROUGH 3 YEARS: EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL
Hall, S.
Mease, P.
Kavanaugh, A.
Reimold, A.
Tahir, H.
Rech, J.
Geusens, P.
Pascale, P.
Delicha, E.
Pricop, L.
Mpofu, S.
INTERNAL MEDICINE JOURNAL, 2017, 47 : 37 - 38
[7] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 104 WEEKS RESULTS FROM A PHASE 3 TRIAL
McInnes, Iain B.
Mease, Philip
Ritchlin, Christopher T.
Rahman, Proton
Gottlieb, Alice B.
Kirkham, Bruce
RHEUMATOLOGY, 2017, 56 : 76 - 76
[8] Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 104 Weeks Results from a Phase 3 Trial
McInnes, Kin B.
Mease, Philip J.
Ritchlin, Christopher T.
Rahman, Proton
Gottlieb, Alice B.
Kirkham, Bruce
Kajekar, Radhika
Delicha, Evie Maria
Pricop, Luminita
Mpofu, Shephard
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[9] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 104 WEEKS RESULTS FROM A PHASE 3 TRIAL, FUTURE 2
McInnes, I. B.
Mease, P. J.
Ritchlin, C.
Rahman, P.
Gottlieb, A.
Kirkham, B.
Kajekar, R.
Delicha, E. M.
Pricop, L.
Mpofu, S.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 145 - 145
[10] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 4-YEAR RESULTS FROM THE PHASE 3 FUTURE 2 STUDY
McInnes, Iain B.
Kirkham, Bruce
Nash, Peter
Rahman, Proton
Gottlieb, Alice B.
Ding, Kevin
Pricop, Luminita
RHEUMATOLOGY, 2019, 58

← 1 2 3 4 5 →